|
Strides Pharma and Lupin Pharmaceuticals voluntarily recalled the batches/lots of Losartan Potassium tablets in USA due to AZIDO Impurity levels observed to be above acceptable limits
|
|
0
|
261
|
June 16, 2022
|
|
Stress condition in COC impurity
|
|
6
|
755
|
May 24, 2022
|
|
Sandoz recalls 13 lots of Orphenadrine citrate 100 mg ER tablets
|
|
8
|
816
|
May 3, 2022
|
|
ANVISA finally approved new resolution for conrtol of Nitrosamines in Brazil
|
|
0
|
424
|
April 29, 2022
|
|
Voluntary Recall of lots of ACCUPRIL tablets
|
|
1
|
464
|
April 26, 2022
|
|
Recall of lots of Accuretic tablets by Pfizer
|
|
5
|
672
|
April 25, 2022
|
|
Lupin Pharmaceuticals issues nationwide recall of Irbesartan Tablets
|
|
5
|
859
|
March 22, 2022
|
|
Azithromycin - presence of N-Nitrosamines
|
|
8
|
899
|
March 3, 2022
|
|
Nitrosamines :Authorities Expectations and Typical Mistakes
|
|
0
|
383
|
February 23, 2022
|
|
Nitrosamine impurity in Bumetanide tablets
|
|
2
|
992
|
February 11, 2022
|
|
FDA recommendations for minimisation of Nitrosamine related Imps through formulation design changes
|
|
0
|
261
|
February 9, 2022
|
|
Metformin Recall mktd by Viona Pharmaceuticals Inc
|
|
4
|
407
|
January 20, 2022
|
|
Https://www.fda.gov/media/154487/download
|
|
0
|
307
|
December 8, 2021
|
|
USP- Approved <1469> Nitrosamines Impurities
|
|
1
|
1197
|
December 6, 2021
|
|
Health Canada - Urgent Public Health needed due Nitrosamine
|
|
1
|
294
|
November 16, 2021
|
|
TGA, Australia Recalls Sartans due to Azide Impurity
|
|
0
|
356
|
October 15, 2021
|
|
Summary of current Nitrosamine Regulatory scenario
|
|
0
|
287
|
October 15, 2021
|
|
FDA alerts to a voluntary recall of varenicline - What do we know?
|
|
17
|
1292
|
September 30, 2021
|
|
So… the Nitrosamines crisis unfolding into judicial consequences
|
|
0
|
303
|
September 13, 2021
|
|
CDER conducts Lab & Clinical studies to evaluate NDMA production from Ingested Ranitidine products
|
|
0
|
242
|
September 8, 2021
|
|
MHRA recalls Metformin Oral solution
|
|
14
|
409
|
September 3, 2021
|
|
Brazilian focus on Nitrosamines
|
|
0
|
250
|
August 26, 2021
|
|
FDA rejects the extension of deadlines for submission of Nitrosamine Risk Assessments
|
|
0
|
223
|
August 11, 2021
|
|
Health Canada Safety Recall - NMOA
|
|
3
|
341
|
July 13, 2021
|
|
European supplier recalling due AZBT?
|
|
11
|
474
|
July 9, 2021
|
|
Nitrosamine Implementation Oversight Group (NIOG) Workplan and topics for QWP & SWP IP Meetings
|
|
0
|
205
|
April 15, 2021
|
|
EU Nitrosamines Oversight Group Identifies Priority Topics
|
|
0
|
232
|
April 15, 2021
|